Editorial: T-cell directed therapies in multiple myeloma

• Joshua Richter,
• Larry D. Anderson,
• Karthik Ramasamy,
• Karthik Ramasamy,
• Adriana Rossi

Affiliations

Joshua Richter

Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, United States

Larry D. Anderson

Myeloma, Waldenstrom’s, and Amyloidosis Program, Simmons Comprehensive Cancer Center, University of Texas (UT) Southwestern Medical Center, Dallas, TX, United States

Karthik Ramasamy

Radcliffe Department of Medicine, Oxford University Hospitals National Health Services (NHS) Foundation Trust, Oxford, United Kingdom

Karthik Ramasamy

Oxford Translational Myeloma Centre, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS), University of Oxford, Oxford, United Kingdom

Adriana Rossi

Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, United States